abstract |
The present invention relates to biomarkers for predicting susceptibility to protein kinase inhibitors and their uses, and provides markers, compositions, kits, and methods for predicting susceptibility to protein kinase inhibitors. According to the present invention, since the effect of predicting susceptibility to a protein kinase inhibitor is excellent, the present invention can be usefully used for cancer treatment. |